Genotech Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 3.20 M
as on 24-10-2024
- Paid Up Capital ₹ 3.20 M
as on 24-10-2024
- Company Age 14 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.00 M
as on 24-10-2024
- Revenue -59.75%
(FY 2023)
- Profit -71.41%
(FY 2023)
- Ebitda -144.45%
(FY 2023)
- Net Worth 4.26%
(FY 2023)
- Total Assets 1.88%
(FY 2023)
About Genotech Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.20 M and a paid-up capital of Rs 3.20 M.
The company currently has active open charges totaling ₹3.00 M.
Thaduri Srivani, Ravi Pericherla, Suryanarayana Kolagani, and One other member serve as directors at the Company.
- CIN/LLPIN
U24232TG2010PTC068845
- Company No.
068845
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Jun 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Genotech Pharmaceuticals Private Limited offer?
Genotech Pharmaceuticals Private Limited offers a wide range of products and services, including Industrial Chemicals & Supplies, Chemical Intermediates, Organic and Inorganic Solvents, Alcohol Solvents, Intermediate Chemicals, API (Active Pharmaceutical Ingredients), API Intermediate, Cleaning Liquids & Wipes, Degreasing Chemicals, Chemical Reagents & Catalysts.
Who are the key members and board of directors at Genotech Pharmaceuticals?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Thaduri Srivani  | Director | 25-May-2021 | Current |
| Ravi Pericherla | Director | 13-Jul-2018 | Current |
| Suryanarayana Kolagani | Director | 15-Jun-2018 | Current |
| Murari Rajakumari | Director | 25-May-2021 | Current |
Financial Performance of Genotech Pharmaceuticals.
Genotech Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 59.75% decrease. The company also saw a substantial fall in profitability, with a 71.41% decrease in profit. The company's net worth moved up by a moderate rise of 4.26%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Genotech Pharmaceuticals?
In 2023, Genotech Pharmaceuticals had a promoter holding of 56.00% and a public holding of 44.00%. The company had 3 Associate Companies. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Stereokem Pharmaceuticals Private LimitedActive 12 years 10 monthsThaduri Srivani is a mutual person
- Genotech Health And Life Sciences Private LimitedActive 8 years 6 months
Ravi Pericherla and Suryanarayana Kolagani are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Dhanlaxmi Bank Limited Creation Date: 08 Feb 2017 | ₹3.00 M | Open |
How Many Employees Work at Genotech Pharmaceuticals?
Unlock and access historical data on people associated with Genotech Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Genotech Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Genotech Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
